(128 days)
No
The document does not mention AI, ML, or any related terms like deep learning or neural networks. The description focuses on standard ultrasound technology and signal processing.
No.
The device is clearly described as an "Ultrasound Diagnostic System" intended for "ultrasound imaging, measurement, display and analysis," which are diagnostic rather than therapeutic functions.
Yes
The "Intended Use / Indications for Use" section explicitly states "The HD60 Series Ultrasound Diagnostic System is a general-purpose ultrasound system." and "The HD60 series Diagnostic Ultrasound System is applicable for adults, pregnant woments and neonates."
No
The device description explicitly states it consists of a mobile console with hardware components like a control panel, displays, transducers, and electronics for transmitting and receiving ultrasound data. It is a physical ultrasound system, not software only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information about a person's health.
- Device Function: The HD60 Series Ultrasound Diagnostic System uses ultrasound waves to create images of structures within the human body. It does not analyze specimens taken from the body.
- Intended Use: The intended use clearly states it is for "ultrasound imaging, measurement, display and analysis of the human body and fluid." This describes an in-vivo (within the living body) diagnostic process, not an in-vitro one.
Therefore, the HD60 Series Ultrasound Diagnostic System is a diagnostic imaging device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The HD60 Series Ultrasound Diagnostic System is a general-purpose ultrasound system. It is intended for use by, or under the direction of a qualified and trained physician for ultrasound imaging, measurement, display and analysis of the human body and fluid. The device is intended for use in a hospital environment.
The systems support the following clinical applications:
The HD60 series Diagnostic Ultrasound System is applicable for adults, pregnant women, pediatric patients and neonates. It is intended for use in fetal, abdominal, pediatric, small organ, neonatal and adult cephalic, trans-rectal, trans-vaginal, musculo-skeletal (conventional, superficial), cardiac (adult, pediatric), peripheral vessel, and urology exams.
Modes of operation include: 3D/4D Imaging mode, B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Harmonic Imaging, Combined modes: B/M, B/Color M, B/PWD or CWD, B/Color/PWD or CWD, B/Power/PWD.
Product codes
IYN, IYO, ITX
Device Description
The HD60 Series consists of a mobile console with a height-adjustable control panel, color LCD touch panel, LCD display monitor and optional image storage and printing device. It includes a variety of electronic array transducers operating in linear, curved, sector/phase array, and real time 3D transducer. HD60 series is a Track 3 diagnostic ultrasound system. The system includes electronics for transmit and receive of ultrasound data, ultrasound signal processing, software computing, hardware for image storage, hard copy printing, and network access to the facility through LAN or Wireless with WIFI adapter module.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
fetal, abdominal, pediatric, small organ, neonatal and adult cephalic, trans-rectal, trans-vaginal, musculo-skeletal (conventional, superficial), cardiac (adult, pediatric), peripheral vessel, and urology
Indicated Patient Age Range
adults, pregnant women, pediatric patients and neonates
Intended User / Care Setting
qualified and trained physician / hospital environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The subject of this premarket submission, did not require clinical studies to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/2 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is a symbol of the Department of Health & Human Services-USA. To the right of the symbol, there is the text "FDA U.S. FOOD & DRUG ADMINISTRATION" in blue. The word "FDA" is in a blue square.
February 21, 2024
Qingdao Hisense Medical Equipment Co., Ltd Yalan Wu Regulatory Affair Manager No. 399 Songling Road, Laoshan District Qingdao, Shandong, 266100 CHINA
Re: K233439
Trade/Device Name: HD60 Series Ultrasound Diagnostic System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: Class II Product Code: IYN, IYO, ITX Dated: January 23, 2024 Received: January 23, 2024
Dear Yalan Wu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product;
1
and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including. but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combinationproducts/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reporting-mdr-howreport-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medical-devices/deviceadvice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/trainingeducation/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumereducation-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Marjan Nabili -S for
Yanna Kang, Ph.D. Assistant Director Mammography and Ultrasound Team DHT8C: Division of Radiological Imaging and Radiation Therapy Devices OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K233439
Device Name HD60 Series Ultrasound Diagnostic System
Indications for Use (Describe)
The HD60 Series Ultrasound Diagnostic System is a general-purpose ultrasound system. It is intended for use by, or under the direction of a qualified and trained physician for ultrasound imaging, measurement, display and analysis of the human body and fluid. The device is intended for use in a hospital environment.
The systems support the following clinical applications:
The HD60 series Diagnostic Ultrasound System is applicable for adults, pregnant woments and neonates. It is intended for use in fetal, abdominal, pediatric, small organ, neonatal and adult cephalic, trans-rectal, musculo-skeletal (conventional, superficial), cardiac (adult, pediatric), peripheral vessel, and urology exams.
Modes of operation include: 3D/4D Imaging mode. B. M. PW Doppler, Color Doppler, Color M Doppler, Power Doppler, Harmonic Imaging, Combined modes: B/M, B/Color M, B/Color/PWD or CWD, B/Power/PWD.
| Type of Use (Select one or both, as applicable) | ||||
|---|---|---|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) | Prescription Use (Part 21 CFR 801 Subpart D) | Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) | Over-The-Counter Use (21 CFR 801 Subpart C) |
| Prescription Use (Part 21 CFR 801 Subpart D) | Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) | Over-The-Counter Use (21 CFR 801 Subpart C) | |
| Prescription Use (Part 21 CFR 801 Subpart D) | ||||
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
K233439
In accordance with 21 CFR 807.92 the following summary of information is provided:
| Date Prepared: | Sep 26, 2023 |
|---|---|
| Manufacturer: | Qingdao Hisense Medical Equipment Co., Ltd |
| No. 399 Songling Road, Laoshan District | |
| 266100, Qingdao, Shandong, P. R. China | |
| Contact Person: | Yalan Wu |
| Regulatory Affair Manager | |
| Qingdao Hisense Medical Equipment Co., Ltd |
Tel: +86-532-55752797 wuyalan@Hisense.com
ldentification of the Device:
| Proprietary/Trade Name: | HD60 Series Ultrasound Diagnostic System |
|---|---|
| Classification Name: | Ultrasound Diagnostic System |
| Regulation Name: | Ultrasonic Pulsed Doppler Imaging System |
| Regulatory Number: | 21 CFR 892.1550, 21 CFR 892.1560, 21 CFR 892.1570 |
| Product Code: | IYN, IYO, ITX |
| Device Class: | Class II |
| Review Panel: | Radiology |
Primary Predicate Device:
| Proprietary/Trade Name: | HD60 Series Ultrasound Diagnostic System |
|---|---|
| Classification Name: | Ultrasound Diagnostic System |
| Regulation Name: | Ultrasonic Pulsed Doppler Imaging System |
| Regulatory Number: | 21 CFR 892.1550, 21 CFR 892.1560, 21 CFR 892.1570 |
| Product Code: | IYN, IYO, ITX |
| Device Class: | Class II |
| Review Panel: | Radiology |
| Submitter/510(k) Holder: | Qingdao Hisense Medical Equipment Co., Ltd |
4
510(k) Premarket Notification Submission
| Clearance: | K213862 (cleared June 8, 2022) |
|---|---|
| Reference Device (1): | |
| Trade Name: | DC-80/DC-80PRO/DC-80EXP/DC-80S/DC-85 |
| /DC-86/DC-86S/DC-89/DC-TV/DC-TQ | |
| Classification Name: | Ultrasound Diagnostic System |
| Regulation Name: | Ultrasonic Pulsed Doppler Imaging System |
| Regulatory Number: | 21 CFR 892.1550, 1560, 1570 |
| Product Code: | IYN, IYO, ITX, LLZ |
| Device Class: | Class II |
| Review Panel: | Radiology |
| Submitter/510(k) Holder: | Shenzhen Mindray Bio-medical Electronics Co., |
| LTD. | |
| Clearance: | K192152 (cleared December 13, 2019) |
| Reference Device (2): | |
| Trade Name: | Resona R9, Resona R9 Exp, Resona R9 Pro, |
| Resona R9S, Nuewa R9, Nuewa R9 Exp, | |
| Nuewa R9 Pro, Nuewa R9S, Resona 7, | |
| Resona 7CV, Resona 7EXP, Resona 7S, | |
| Resona 7OB, Resona 7PRO, Imagyn 7, | |
| Resona Y, Resona R9W, Resona R7W, | |
| Nuewa R9W, Nuewa R7W | |
| Classification Name: | Ultrasound Diagnostic System |
| Regulation Name: | Ultrasonic Pulsed Doppler Imaging System |
| Regulatory Number: | 21 CFR 892.1550, 1560, 1570 |
| Product Code: | IYN, IYO, ITX |
| Device Class: | Class II |
| Review Panel: | Radiology |
| Submitter/510(k) Holder: | Shenzhen Mindray Bio-medical Electronics Co., |
| LTD. | |
| Clearance: | K222928 (cleared Feb 7, 2023) |
Device Description:
The HD60 Series consists of a mobile console with a height-adjustable control panel, color LCD touch panel, LCD display monitor and optional image storage and printing device. It includes a variety of electronic array transducers operating in linear, curved, sector/phase array, and real time 3D transducer. HD60 series is a Track 3 diagnostic ultrasound system. The system includes electronics for transmit and receive of ultrasound data, ultrasound signal processing, software computing, hardware for image storage, hard copy
5
printing, and network access to the facility through LAN or Wireless with WIFI adapter module.
Indications for Use:
The HD60 Series Ultrasound Diagnostic System is a general-purpose ultrasound system. It is intended for use by, or under the direction of a qualified and trained physician for ultrasound imaging, measurement, display and analysis of the human body and fluid. The device is intended for use in a hospital environment.
The systems support the following clinical applications:
The HD60 series Diagnostic Ultrasound System is applicable for adults, pregnant women, pediatric patients and neonates. It is intended for use in fetal, abdominal, pediatric, small organ, neonatal and adult cephalic, trans-rectal, trans-vaginal, musculo-skeletal (conventional, superficial), cardiac (adult, pediatric), peripheral vessel, and urology exams.
Modes of operation include: 3D/4D Imaging mode, B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Harmonic Imaging, Combined modes: B/M, B/Color M, B/PWD or CWD, B/Color/PWD or CWD, B/Power/PWD.
Comparison with Predicate Device:
The HD60 series Ultrasound Diagnostic System and its predicate device, the previous generation of HD60 series Ultrasound Diagnostic System (K213862), have the same intended use, and similar physical characteristics.
Technology:
The HD60 Series employs the same fundamental scientific technology as its predicated device.
Determination of substantial equivalence:
The Proposed HD60 Series system are substantially equivalent to the predicate HD60 Series Ultrasound Diagnostic System (K213862) with regards to intended use, indication for use, image capabilities, technological characteristics, image mode, and safety effectiveness.
The changes base on previous HD60 series Ultrasound Diagnostic System as below:
Note 1: Patient Contact Materials.
The Patient Contact Materials of the new added probes is equivalent to the predicated device, both the subject and predicated device probe material meet ISO 10993-1 and FDA guidance requirement. They can be considered
6
Substantially Equivalent in safety and effectiveness, and no new risk is raised, so the SE is not affected.
Note 2: Functions.
(1) New added functions which is same as reference device CAMM (Curved Anatomy M-Mode), HiNeedle, Biopsy, Echo Enhance, TDI QA, C-Elasto, Contrast (Contrast Imaging), Auto Track, R Flow (Ribbon Flow), Dual Live, HiStep, DVR, Gesture Settings, Voice Comment, MFI (Micro Flow Imaging): are new functions compare with predicate device. These features are exactly same as the Diagnostic Ultrasound System model DC-80 (K192152 cleared December 13, 2019), and Resona 7 (K222928 (cleared Feb 7, 2023) manufactured by Mindray. The SE is not affected.
(2) New added functions which is not support on predicated/reference device There are three functions of 3D PW (3DSpectral), SCV(Spectral Color Velocity), and MSV(Multi-sample volume) which are not support on predicated/reference device. The performance of them all meets the requirements. These new function has no impact on safety or effectiveness.
The three new added functions of the HD60 series are features that are used to characterize blood flow measurements.
Note 3: Measurements.
New added measurement of Pelvic Floor Measurement kit, Obstetric Auto Measurement, Auto NT Measurement, Cardiac Auto measurement which are same as reference, the Diagnostic Ultrasound System model DC-80 manufactured by Mindray (K192152 cleared December 13, 2019). The SE is not affected.
Note 4: WIFI.
Adding WIFI module, and the device support wireless function to connect LAN. The device with WIFI module was verified on safety/EMC, software and cybersecurity, The SE is not affected.
Note 5: Other change.
(1) Product console models change:
Total 93 console models after adding/deleting console models, the difference between the models are software functions. The model list as below: HD60、HD60S、HD60G、HD60Q、HD60T、HD60E、HD60EXP、 HD60Pro; HD58EXP、HD58Pro、HD58Plus、HD58; HD59EXP、 HD59Pro、HD59Plus、HD59; HD62EXP、HD62Pro、HD62Plus、HD62; HD55、HD55S、HD55G、HD55Q、HD55T、HD55E、HD55Plus: HD50、
7
510(k) Premarket Notification Submission
HD50S、HD50G、HD50Q、HD50T、HD50E、HD50Plus: HD48、HD48S、 HD48G、HD48Q、HD48T、HD48E、HD48Plus; HD45、HD45S、HD45G、 HD45Q、HD45T、HD45E、HD45Plus; HD42、HD42S、HD42G、HD42G、HD42Q、 HD42T、HD42E、HD42Plus; HD40、HD40S、HD40G、HD40Q、HD40T、 HD40E、HD40Plus; HD35、HD35S、HD35G、 HD35Q、HD35T、 HD35E、HD35Plus; HD30、HD30S、HD30G、HD30Q、HD30T、HD30E、 HD30EXP、HD30Pro; HD25、HD25S、HD25G、HD25Q、HD25T、 HD25E、HD25EXP、HD25Pro; HD20、HD20S、HD20G、HD20Q、 HD20T、HD20E、HD20EXP、HD20Pro;
(2) Adding new probes models
Total support 30 probe models after adding/deleting probes: L15-5EL, L12-3EB, L15-5EB, L15-5E, L9-3E, L14-6E, L9-3A, L12-4L, L12-3E, SC7-1E, SC8-2E, C5-2A, C5-2L, C5-1E, P5-1A, P8-2EJ, P4-1EL, P4-1EB, P4-1L, P4-1E, E9-3E, E9-4E, E9-4EL, E9-4L, E9-4B, DC6-2A, DC7-2A, DE10-3E, MC11-3A, ECL11-4E.
The new added probes have same indication for use, and equivalent material. (3) Optimize software function
DICOM preset (such as image print preset, enquire or store preset) optimize. Above modifications can be considered Substantially Equivalent in safety and effectiveness, and no new risk is raised, so the SE is not affected.
Summary of Non-clinical test:
HD60 Series were evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic, and mechanical safety, and have been found to comply with applicable medical device safety standard, The HD60 Series complies with voluntary standards:
-
- ANSI AAMI ES60601-1:2005/(R)2012 & A1:2012, C1:2009/(R)2012 & A2:2010/(R)2012 (Cons. Text) [Incl. AMD2:2021] Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005, MOD) [Including Amendment 2 (2021)]
-
- IEC 60601-1-2 Edition 4.1 2020-09 CONSOLIDATED VERSION Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests
-
- IEC/TR 60601-4-2 Edition 1.0 2016-05 Medical electrical equipment Part 4-2: Guidance and interpretation - Electromagnetic immunity: performance of medical electrical equipment and medical electrical systems
-
- IEC 60601-2-37 Edition 2.1 2015 Medical electrical equipment Part 2-37: Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment
8
510(k) Premarket Notification Submission
-
- IEC62359. Ultrasonics-Field characterization- Test methods for the determination of thermal and mechanical indices related to medical diagnostic ultrasonic fields. 2017.
-
- ISO10993-1 Fifth edition 2018-08 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
-
- ISO 10993-5 Third edition 2009-06-01 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
-
- ISO 10993-10 Fourth edition 2021-11 Biological evaluation of medical devices - Part 10: Tests for skin sensitization
-
- ISO10993-23 First edition 2021-01 Biological evaluation of medical devices - Part 23: Tests for irritation
-
- ISO14971 Third Edition 2019-12 Medical devices - Application of risk management to medical devices
-
- NEMAPS 3.1 3.20 2022d Digital I Imaging and Communications I in Medicine (DICOM) Set.
-
- IEC60601-1-6 Edition 3.2 2020-07 CONSOLIDATED VERSION Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability
-
- IEC62366-1 Edition 1.1 2020-06 CONSOLIDATED VERSION | Medical devices - Part 1: Application of usability engineering to medical devices
- 14.IEC62304 Edition 1.1 2015-06 CONSOLIDATED VERSION Medical device software - Software life cycle processes
- 15.ISTA3B 2017 Packaged-Products for for Less-Than-Truckload (LTL) Shipment
Summary of Clinical Tests:
The subject of this premarket submission, did not require clinical studies to support substantial equivalence.
Conclusion:
Hisense Considers the HD60 Series Ultrasound Diagnostic System to be as safe, as effective, and performance is substantially equivalent to the predicate device.